BCAT1 and childhood onset asthma: BCAT1 is upregulated in mice with neonatal asthma, and BCAT1 inhibitors may inhibit airway inflammation and remodeling by reducing autophagy, which may provide a new therapeutic direction for childhood asthma (Li et al., 2022).